You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 123 No. 8, August 2005 TABLE OF CONTENTS
  Archives
  •  Online Features
  Clinical Sciences
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (22)
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Similar articles in this journal
 Topic Collections
 •Endophthalmitis
 •Alert me on articles by topic

Acute Endophthalmitis Incidence

Intravitreal Triamcinolone

Andrew C. Westfall, MD; Alexander Osborn, PhD; Derek Kuhl, PhD, MD; Matthew S. Benz, MD; William F. Mieler, MD; Eric R. Holz, MD

Arch Ophthalmol. 2005;123:1075-1077.

Objective  To report the incidence of acute postinjection endophthalmitis following intravitreal injection of triamcinolone acetonide (IVTA) as an office procedure.

Methods  Retrospective, noncomparative, consecutive, interventional case series of all patients who had received IVTA at 2 clinical centers between January 1, 2000, and January 30, 2004.

Results  A total of 1006 eyes received IVTA. None of the eyes developed acute, culture-positive, postoperative endophthalmitis in the 6 weeks following the procedure. One patient developed acute, culture-negative, postoperative endophthalmitis 4 days after receiving IVTA, resulting in an incidence of 0.10%. In this case, the presenting symptoms were decreased vision and acute conjunctival erythema. The case was notable for the absence of pain or hypopyon.

Conclusion  Although acute postoperative endophthalmitis may follow IVTA, our experience suggests that this is a relatively uncommon event.


Author Affiliations: Department of Ophthalmology, Baylor College of Medicine, Houston, Tex (Drs Westfall, Osborn, Benz, Mieler, and Holz); and Austin Retina Associates, College Station, Tex (Dr Kuhl). Dr Mieler is now with the Department of Ophthalmology, University of Chicago, Chicago, Ill.


RELATED LETTER

Sterile Endophthalmitis After Benzyl Alcohol–Filtered Triamcinolone Acetonide Injection
José Lorenzo Carrero, Miguel González Barcia, and Ines Pérez Flores
Arch Ophthalmol. 2008;126(1):142-143.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Increased incidence of sterile endophthalmitis following intravitreal preserved triamcinolone acetonide
Jonisch et al.
Br. J. Ophthalmol. 2008;92:1051-1054.
ABSTRACT | FULL TEXT  

Sterile Endophthalmitis After Benzyl Alcohol Filtered Triamcinolone Acetonide Injection
Lorenzo Carrero et al.
Arch Ophthalmol 2008;126:142-143.
FULL TEXT  

Management of Diabetic Retinopathy: A Systematic Review
Mohamed et al.
JAMA 2007;298:902-916.
ABSTRACT | FULL TEXT  

A 76-year-old man with macular degeneration.
Arroyo
JAMA 2006;295:2394-2406.
FULL TEXT  

Methotrexate reduces the complications of endophthalmitis resulting from intravitreal injection compared with dexamethasone in a rabbit model.
Deng et al.
IOVS 2006;47:1516-1521.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2005 American Medical Association. All Rights Reserved.